相似文献
1
N-of-1 tests in general practice: pharmacological considerations.
Br J Gen Pract. 2025 Feb 27;75(752):132-135. doi: 10.3399/bjgp25X740985. Print 2025 Mar.
2
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
3
Implementation of a Quality Improvement and Clinical Decision Support Tool for Cancer Diagnosis in Primary Care: Process Evaluation.
JMIR Cancer. 2025 Jun 12;11:e65461. doi: 10.2196/65461.
4
Pharmacological interventions for the treatment of disordered and problem gambling.
Cochrane Database Syst Rev. 2022 Sep 22;9(9):CD008936. doi: 10.1002/14651858.CD008936.pub2.
5
Do longer consultations improve the management of psychological problems in general practice? A systematic literature review.
BMC Health Serv Res. 2007 May 17;7:71. doi: 10.1186/1472-6963-7-71.
6
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals.
Can J Psychiatry. 2025 Feb 12:7067437241303031. doi: 10.1177/07067437241303031.
7
Pharmacological interventions for self-harm in adults.
Cochrane Database Syst Rev. 2021 Jan 10;1(1):CD013669. doi: 10.1002/14651858.CD013669.pub2.
8
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.
PLoS One. 2017 Jan 5;12(1):e0168549. doi: 10.1371/journal.pone.0168549. eCollection 2017.
9
Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature.
J Psychiatr Pract. 2025 Mar 1;31(2):56-64. doi: 10.1097/PRA.0000000000000845.
10
Determinants of medical student's perception of general practice.
Br J Gen Pract. 2024 Jun 20;74(suppl 1):bjgp24X737913. doi: 10.3399/bjgp24X737913.
本文引用的文献
1
N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.
Br J Clin Pharmacol. 2022 Oct;88(10):4460-4473. doi: 10.1111/bcp.15442. Epub 2022 Jul 13.
2
N-of-1 Trials in Neurology: A Systematic Review.
Neurology. 2022 Jan 11;98(2):e174-e185. doi: 10.1212/WNL.0000000000012998. Epub 2021 Oct 21.
3
Status of N-of-1 Trials in Chronic Pain Management: A Narrative Review.
Pain Ther. 2021 Dec;10(2):1013-1028. doi: 10.1007/s40122-021-00314-4. Epub 2021 Sep 16.
4
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
BMJ. 2021 Feb 24;372:n135. doi: 10.1136/bmj.n135.
5
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
N Engl J Med. 2020 Nov 26;383(22):2182-2184. doi: 10.1056/NEJMc2031173. Epub 2020 Nov 15.
6
Personalized (N-of-1) Trials for Depression: A Systematic Review.
J Clin Psychopharmacol. 2018 Jun;38(3):218-225. doi: 10.1097/JCP.0000000000000864.
7
The history and development of N-of-1 trials.
J R Soc Med. 2017 Aug;110(8):330-340. doi: 10.1177/0141076817721131.
8
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement.
J Clin Epidemiol. 2016 Aug;76:9-17. doi: 10.1016/j.jclinepi.2015.05.004. Epub 2015 Aug 10.
9
How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.
Heart. 2011 Nov;97(21):1771-5. doi: 10.1136/hrt.2010.221473. Epub 2011 May 17.
10
N-of-1 trials in the medical literature: a systematic review.
Med Care. 2011 Aug;49(8):761-8. doi: 10.1097/MLR.0b013e318215d90d.
Zotero 插件